Opko Health OPK Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Gross Profit by Business | |||||
| Diagnostics | $62.92M-19.9% | $78.56M+13.1% | $69.45M-45.8% | $128.08M— | |
| Pharmaceutical | $143.02M+2.2% | $139.95M-43.7% | $248.68M— | —— | |
| Revenue by Product | |||||
| Rayaldee | $59.39M-14.3% | $69.3M+2.6% | $67.55M+13.4% | $59.56M-7.4% | |
| Transfer Of Intellectual Property And Other | $79.7M+3.0% | $77.4M-57.2% | $180.73M+70.9% | $105.76M+469% | |
| Revenue by Geography | |||||
| CL | $62.38M-4.1% | $65.05M-5.0% | $68.49M+10.4% | $62.04M-2.8% | |
| ES | $26.72M+8.5% | $24.63M+4.7% | $23.52M+4.6% | $22.48M-0.9% | |
| IE | $51.4M+6.2% | $48.4M-65.8% | $141.47M+20.7% | $117.22M+257% | |
| IL | $523K-70.5% | $1.77M-81.8% | $9.74M+153% | $3.85M+7.9% | |
| MX | $25.52M+6.9% | $23.87M+18.1% | $20.22M+39.0% | $14.55M+32.2% | |
| Other Countries | $4.27M+36.8% | $3.12M+39.1% | $2.25M+160% | $862K+70.0% | |
| US | $436.06M-20.2% | $546.3M-8.6% | $597.82M-23.7% | $783.21M-52.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Opko Health break its business down?
- Opko Health (OPK) reports gross profit by business across 2 parts — Diagnostics and Pharmaceutical. Each is extracted from the segment footnotes and tracked over time.
- Where does Opko Health's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Opko Health's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
